⌘K

Home/Insiders/Bashan Dror

BD

SEC Insider//CIK 0001781450

Bashan Dror

CIK 00017814501 companyCARMIEL, L3

Transactions

12

Companies

1

Filings

10

CIK

0001781450

Recent Transactions

12 trades

Award
Protalix BioTherapeutics, Inc.$PLX
Stock Option (Right to Buy)
2025-09-03+340,000→ 340,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2025-09-03+195,000→ 2,344,418 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2024-04-01+263,960→ 2,149,418 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2023-10-19$1.40/sh+48,387→ 116,387 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2023-10-19$1.41/sh+16,129→ 132,516 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2023-08-15+800,000→ 1,885,458 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2022-09-07+750,000→ 750,000 total
Purchase
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2022-04-11$1.50/sh+68,000→ 68,000 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2022-02-25+637,531→ 1,085,458 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2020-08-11+447,927→ 447,927 total
Award
Protalix BioTherapeutics, Inc.$PLX
Common Stock
2020-08-11+447,927→ 447,927 total
Award
Protalix BioTherapeutics, Inc.$PLX
Stock Options (Right to Buy)
2019-06-30+1,600,000→ 1,600,000 total

Companies

1

Protalix BioTherapeutics, Inc.
Director, PRESIDENT AND CEO
$PLX

Recent Filings

10

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET SCIENCE PARK, POB 455

CARMIEL, L3, 2161401

View on SEC.gov